Combined Intermittent Pneumatic Leg Compression and Pharmacological Prophylaxis for Prevention of Venous Thrombo-Embolism in High-Risk Patients  by Kakkos, S.K. et al.
Eur J Vasc Endovasc Surg (2009) 37, 364e365COCHRANE REVIEW UPDATE
Combined Intermittent Pneumatic Leg Compression
and Pharmacological Prophylaxis for Prevention of
Venous Thrombo-Embolism in High-Risk Patients*S.K. Kakkos*,1, J.A. Caprini 2, G. Geroulakos 3, A.N. Nicolaides 4,
G.P. Stansby 5, D.J. Reddy 11 Division of Vascular Surgery, Department of Surgery, Detroit, USA
2 Department of Surgery, Evanston Northwestern Healthcare,Evanston, USA
3 Vascular Unit and Department of Vascular Surgery, Ealing Hospital and Imperial College, London, Southall, UK
4 Vascular Screening and Diagnostic Centre, and Cyprus University, Nicosia , Cyprus
5 Department of Surgery, University of Newcastle upon Tyne, Newcastle upon Tyne, UK
Submitted 21 October 2008; accepted 18 November 2008
Available online 21 January 2009KEYWORDS
DVT;
PE;
VTE* Published in The Cochrane Library
* Corresponding author. S. K. Kakk
Surgery, University of Patras Medica
2610 999360.
E-mail address: kakkos@upatras.gr
1078-5884/$34 ª 2008 Published by E
doi:10.1016/j.ejvs.2008.11.033Abstract Background: It has been suggested that combined modalities (methods of treat-
ment) are more effective than single modalities in preventing venous thrombo-embolism
(defined as deep vein thrombosis and pulmonary embolism, or both) in high-risk patients.
Objectives: To assess the efficacy of intermittent pneumatic leg compression combined with
pharmacological prophylaxis versus single modalities in preventing venous thrombo-embolism
in high-risk patients.
Search strategy: The Cochrane Peripheral Vascular Diseases (PVD) Group searched the refer-
ence lists of their Specialised Register (last searched 17 July 2007) and the Cochrane Central
Register of Controlled Trials (CENTRAL) (last searched The Cochrane Library 2008, issue 3) for
relevant articles to identify additional trials.
Selection criteria: Randomised controlled trials (RCTs) or controlled clinical trials (CCTs) of
combined intermittent pneumatic leg compression and pharmacological interventions used
to prevent venous thrombo-embolism in high-risk patients.
Data collection and analysis: Data extraction was undertaken independently by two review
authors using data extraction sheets.
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Combined Intermittent Pneumatic Leg Compression 365a total of 7431 patients. As compared to compression
alone, the use of combined modalities significantly reduced
the incidence of both symptomatic pulmonary embolism
(PE) (from about 3% to 1%; odds ratio (OR) 0.39, 95%
confidence interval (CI): 0.25e0.63) and deep vein throm-
bosis (DVT) (from about 4% to 1%; OR 0.43, 95% CI: 0.24e
0.76). When compared with pharmacological prophylaxis
alone, the use of combined modalities significantly reduced
the incidence of DVT (from 4.21% to 0.65%; OR 0.16, 95% CI:
0.07e0.34) but the included studies were underpowered
with regard to PE. The comparison of compression and
pharmacological prophylaxis together with a combination
of compression and aspirin showed an insignificant reduc-
tion in PE and DVT in favour of the former group. Repeat
analysis restricted to the RCTs confirmed the above
findings.Conclusions
When compared with compression alone, combined
prophylactic modalities decrease the incidence of venous
thrombo-embolism significantly. As compared to pharmaco-
logical prophylaxis alone, combined modalities reduce the
incidence of DVT significantly, but the effect on PE is
unknown. The results of the current review support, espe-
cially in high-risk patients, the use of combined modalities.
More studies on their role in PE prevention, compared with
pharmacological prophylaxis alone, are urgently needed.
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